Multiple sclerosis and Angiotensin converting enzyme increased

Summary:

Angiotensin converting enzyme increased is found among people with Multiple sclerosis, especially for people who are female, 50-59 old.

The study analyzes which people have Angiotensin converting enzyme increased with Multiple sclerosis. It is created by eHealthMe based on reports of 22 people who have Multiple sclerosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Multiple sclerosis?

Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,085 drugs and 1,365 conditions by eHealthMe. Check the latest studies of Multiple sclerosis.

What is Angiotensin converting enzyme increased?

Angiotensin converting enzyme increased is found to be associated with 50 drugs and 161 conditions by eHealthMe. Check the latest studies of Angiotensin converting enzyme increased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 18, 2026

22 people who have Multiple Sclerosis and Angiotensin Converting Enzyme Increased are studied.

Would you have Angiotensin converting enzyme increased when you have Multiple sclerosis?

Gender of people who have Multiple Sclerosis and experienced Angiotensin Converting Enzyme Increased *:

female: 95.24 %
male: 4.76 %

Age of people who have Multiple Sclerosis and experienced Angiotensin Converting Enzyme Increased *:

Common co-existing conditions for these people *:

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 4.55%
High Blood Pressure: 1 person, 4.55%
Dyslipidaemia (abnormal amount of lipids): 1 person, 4.55%

Common drugs taken by these people *:

Common symptoms for these people *:

Sarcoidosis (an inflammatory disease that affects multiple organs in the body, but mostly the lungs and lymph glands): 9 people, 40.91%
Headache (pain in head): 8 people, 36.36%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 5 people, 22.73%
White Blood Cell Count Increased: 4 people, 18.18%
Haemoglobinaemia (excess of haemoglobin in the blood plasma): 4 people, 18.18%
Mean Cell Volume Decreased (less of the average red blood cell volume): 4 people, 18.18%
Mean Cell Haemoglobin Increased (more than normal haemoglobin per red blood cell in a sample of blood): 4 people, 18.18%
Macrocytosis (enlargement of red blood cells with near-constant haemoglobin concentration): 4 people, 18.18%
Lymphocyte Count Decreased: 4 people, 18.18%
Lipase Increased: 4 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Angiotensin converting enzyme increased?

- Check whether Angiotensin converting enzyme increased is associated with a drug or a condition

Related publications that referenced our studies

Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .
Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .

Related studies:

Treatments, associated drugs and conditions:

Multiple sclerosis (799,637 reports)
Angiotensin converting enzyme increased (303 reports)

All the drugs that are associated with Angiotensin converting enzyme increased:

Angiotensin converting enzyme increased (50 drugs)

All the conditions that are associated with Angiotensin converting enzyme increased:

Angiotensin converting enzyme increased (161 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Angiotensin converting enzyme increased and Multiple sclerosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.